Is BHVN or BIOA more undervalued in 2026?

CirclFi compares Biohaven Ltd. (BHVN) and BioAge Labs, Inc. (BIOA) using 13 institutional-grade valuation models. BHVN has a Quality of Company score of 3.8/10 while BIOA scores 5.1/10.

Which is a better buy — BHVN or BIOA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BHVN and BIOA valuations compare?

BHVN at $11.01 and BIOA at $17.29 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BHVN vs BIOA Valuation Comparison 2026 — Intrinsic Value Analysis

BHVN

Pharmaceutical Preparations

Biohaven Ltd.

Quality

3.8

out of 10

Value Trap

LOW

Price

$11.01

Last close

Models

6/13

Active

BIOA

Pharmaceutical Preparations

BioAge Labs, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$17.29

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	BHVN Fair Value	BHVN Upside	BIOA Fair Value	BIOA Upside
Bayesian DCF	Intrinsic	$2.44	-77.8%	$7.24	-58.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	—	—	$1.69	-89.9%
Dynamic NAV	Asset-Based	$2.20	-80.1%	$8.42	-51.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BHVN vs BIOA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BHVN vs BIOA — Which Stock Is More Undervalued?

BIOA scores higher with a 5.1/10 quality rating vs BHVN's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Biohaven Ltd. (BHVN) and BioAge Labs, Inc. (BIOA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BHVN currently trades at $11.01 with a QOC of 3.8/10, while BIOA trades at $17.29 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).